ImmunoCellular Therapeutics Ltd

📍 Calabasas, United States👥 10 employees💰 Last funded Oct 2016
Biotechnology Research🌐 imuc.com
Website LinkedIn
ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has concluded a phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells. ImmunoCellular’s pipeline also includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent glioblastoma; ICT-140, a dendritic cell immunotherapy targeting antigens on ovarian cancer stem cells; and the Stem-to-T-cell research program which engineers the patient’s hematopoietic stem cells to generate antigen-specific cancer-killing T-cells.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ImmunoCellular Therapeutics Ltd?
ImmunoCellular Therapeutics Ltd has 2 investors on record on gritt.io.
When did ImmunoCellular Therapeutics Ltd last raise funding?
The most recent investment in ImmunoCellular Therapeutics Ltd recorded on gritt.io was in October 2016.
What industry is ImmunoCellular Therapeutics Ltd in?
ImmunoCellular Therapeutics Ltd operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ImmunoCellular Therapeutics Ltd based?
ImmunoCellular Therapeutics Ltd is headquartered in Calabasas, United States.